|
Market Closed -
NYSE
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 1.150 USD | +2.68% |
|
-3.36% | -15.44% |
| 08-14 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-14 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Chart calendar Actinium Pharmaceuticals, Inc.
Upcoming events on Actinium Pharmaceuticals, Inc.
No events available
Past events on Actinium Pharmaceuticals, Inc.
| 2025-11-26 | Annual General Meeting | 09:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,08 0,22 -62.55% | 0,00 7,74 - | 0,09 0,09 -2.7% | 17,5 | 0,00 | 17,5 |
|
EBITDA Million USD | Released Forecast Spread | -51,1 0,00 - | -41,3 -48,6 15% | -35,4 -36,6 3.21% | 2,40 | -37,1 | -41,1 |
|
EBIT Million USD | Released Forecast Spread | -51,9 -55,6 6.67% | -42,1 -46,8 10.09% | -36,2 -36,1 -0.27% | 5,20 | -33,3 | -22,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,8 -54,4 10.22% | -38,2 -43,3 11.65% | -33,9 -33,9 -0.04% | 6,30 | -33,0 | -22,2 |
|
Net income Million USD | Released Forecast Spread | -48,8 -54,4 10.22% | -38,2 -43,3 11.65% | -33,9 -33,9 -0.04% | 5,91 | -30,9 | -20,0 |
|
EPS USD | Released Forecast Spread | -1,83 -2,04 10.09% | -1,27 -1,41 10.18% | -1,09 -1,09 -0.46% | 0,18 | -0,67 | -0,39 |
| Announcement Date | 29/03/24 | 31/03/25 | 30/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,09 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 35,0 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -7,30 -14,0 47.85% | -16,4 -8,50 -93.33% | -7,30 -10,4 29.82% | -5,49 -8,30 33.9% | -6,21 -6,70 7.34% | -5,68 -7,50 24.23% | 27,8 -6,70 515.01% | -8,90 | -10,4 | ||||
|
EBIT Million USD | Released Forecast Spread | -7,51 -12,3 38.96% | -16,6 -10,1 -65.47% | -7,50 -11,6 35.55% | -5,69 -10,4 45.48% | -6,41 -6,16 -4.05% | -5,90 -7,56 21.91% | 27,6 -8,15 438.14% | -7,38 | -7,68 | -6,78 | -6,11 | -6,17 | -6,23 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,65 -11,7 43.1% | -15,9 -9,03 -76.52% | -6,88 -10,8 36.26% | -5,13 -9,50 45.97% | -5,94 -5,94 -0.02% | -5,52 -7,32 24.58% | 27,9 -6,20 550.02% | -7,68 | -8,43 | -6,78 | -6,11 | -6,17 | -6,23 |
|
Net income Million USD | Released Forecast Spread | -6,65 -11,7 43.1% | -15,9 -9,03 -76.52% | -6,88 -10,8 36.26% | -5,13 -9,50 45.97% | -5,94 -5,94 -0.02% | -5,52 -7,32 24.58% | 27,9 -6,20 550.02% | -7,68 | -8,43 | -6,78 | -6,11 | -6,17 | -6,23 |
|
EPS USD | Released Forecast Spread | -0,21 -0,37 43.85% | -0,51 -0,29 -75.86% | -0,22 -0,35 36.42% | -0,16 -0,30 47.11% | -0,19 -0,19 0% | -0,18 -0,24 23.4% | 0,89 -0,20 545% | -0,24 | -0,24 | -0,09 | -0,08 | -0,08 | -0,08 |
| Announcement Date | 31/03/25 | 09/05/25 | 08/08/25 | 14/11/25 | 30/03/26 | 08/05/26 | 07/08/26 | - | - | - | - | - | - |
| 2026-10-06 |  | Information meeting | 10:00 |
| 2026-10-07 | | Extraordinary General Meeting | 09:00 |
| 2026-10-07 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-10-13 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
| 2026-10-13 | | Extraordinary General Meeting | 22:00 |
| 2026-10-14 | | Information meeting | 14:30 |
| 2026-10-14 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-14 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-14 | | Information meeting | 08:00 |
Past sector events for Actinium Pharmaceuticals, Inc.
| 2026-10-01 | | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-09-30 | | Information meeting | 13:00 |
| 2026-09-29 | | Extraordinary General Meeting | 02:00 |
| 2026-09-29 | | Information meeting | 08:00 |
| 2026-09-29 | | Information meeting | 08:30 |
| 2026-09-29 | | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-09-28 | | Information meeting | 08:30 |
| 2026-09-28 | | Earnings release - Q2 2026 | |
| 2026-09-28 | | Earnings presentation | 08:00 |
| 2026-09-25 | | Earnings presentation | 09:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATNM Stock
- Calendar Actinium Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
